Sucampo (SCMP) reported earnings of $0.23 per share in its second quarter, beating consensus forecast by a penny. The company�s revenue for the quarter was $51.95 million, up 48.9% on a year-over-year basis. Revenue beat consensus forecast by $3.34 million.

Edge Therapeutics (EDGE) reported a loss of $0.33 per share in its second quarter. The company ended the quarter with $111 million in cash and cash equivalents on its balance sheet.

Loxo Oncology (LOXO) reported a loss of $0.77 per share in its second quarter, missing consensus forecast by 14 cents. The company ended the quarter with $52.9 million in cash and cash equivalents on its balance sheet.

Insys Therapeutics (INSY) reported earnings of $0.13 per share in its second quarter, beating consensus forecast by 6 cents. The company�s revenue for the quarter was $67.12 million, down 13.5% on a year-over-year basis. Revenue beat consensus forecast by $0.22 million.

ArQule (ARQL) reported a loss of $0.07 per share in its second quarter, beating consensus forecast by a penny. The company�s revenue for the quarter was $1.07 million, down 64.3% on a year-over-year basis. Revenue missed consensus forecast by $0.06 million.